BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vaudry H, Leprince J, Chatenet D, Fournier A, Lambert DG, Le Mével JC, Ohlstein EH, Schwertani A, Tostivint H, Vaudry D. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function. Pharmacol Rev 2015;67:214-58. [PMID: 25535277 DOI: 10.1124/pr.114.009480] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Yin L, Li N, Jia W, Wang N, Liang M, Shang J, Qiang G, Du G, Yang X. Urotensin receptor acts as a novel target for ameliorating fasting-induced skeletal muscle atrophy. Pharmacol Res 2022;:106468. [PMID: 36167277 DOI: 10.1016/j.phrs.2022.106468] [Reference Citation Analysis]
2 Gaillard A, Mohamad T, Quan FB, de Cian A, Mosiman C, Tostivint H, Pézeron G. Urp1 and Urp2 act redundantly to maintain spine shape in zebrafish larvae.. [DOI: 10.1101/2022.08.09.503396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu Q, Lu QD, Sun BS, Zhao J, He F, Zhu JZ. Inhibition of U-II/UT signaling ameliorates cystitis-associated bladder hyperactivity by targeting the RhoA/Rho-kinase pathway. Kaohsiung J Med Sci 2022. [PMID: 35766129 DOI: 10.1002/kjm2.12569] [Reference Citation Analysis]
4 Wei Z, Han D, Zhang C, Wang S, Liu J, Chao F, Song Z, Chen G. Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer. Front Oncol 2022;12:893424. [DOI: 10.3389/fonc.2022.893424] [Reference Citation Analysis]
5 Cao J, Ma X, Liu L, Zhang G, Wu Y, Fu Y, Gong A, Yang Z, Zhao Y, Zhang L, Li Y. Cortistatin attenuates titanium particle-induced osteolysis through regulation of TNFR1-ROS-caspase-3 signaling in osteoblasts. Ann N Y Acad Sci 2022. [PMID: 35419858 DOI: 10.1111/nyas.14774] [Reference Citation Analysis]
6 Rex DAB, Suchitha GP, Palollathil A, Kanichery A, Prasad TSK, Dagamajalu S. The network map of urotensin-II mediated signaling pathway in physiological and pathological conditions. J Cell Commun Signal 2022. [PMID: 35174439 DOI: 10.1007/s12079-022-00672-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Karami Y, Murail S, Giribaldi J, Lefranc B, Leprince J, de Vries SJ, Tufféry P. A novel computational method for head-to-tail peptide cyclization: application to urotensin II.. [DOI: 10.1101/2022.01.05.475045] [Reference Citation Analysis]
8 Wang Y. Overviews of avian neuropeptides and peptides. Sturkie's Avian Physiology 2022. [DOI: 10.1016/b978-0-12-819770-7.00046-3] [Reference Citation Analysis]
9 Litmanovich A, Moady G, Saad M, Blumberg Y, Ertracht O, Qvit N. Cardiovascular-derived therapeutic peptidomimetics in cardiovascular disease. Peptide and Peptidomimetic Therapeutics 2022. [DOI: 10.1016/b978-0-12-820141-1.00011-x] [Reference Citation Analysis]
10 Schuster R, Steffen P, Dreyer B, Rohn S, Schlüter H, Riedner M. Identifying Circulating Urotensin II and Urotensin II-Related Peptide-Generating Enzymes in the Human Plasma Fraction Cohn IV-4. J Proteome Res 2021;20:5368-78. [PMID: 34734734 DOI: 10.1021/acs.jproteome.1c00521] [Reference Citation Analysis]
11 Quan FB, Gaillard AL, Alejevski F, Pézeron G, Tostivint H. Urotensin II-related peptide (Urp) is expressed in motoneurons in zebrafish, but is dispensable for locomotion in larva. Peptides 2021;146:170675. [PMID: 34655691 DOI: 10.1016/j.peptides.2021.170675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Alejevski F, Leemans M, Gaillard AL, Leistenschneider D, de Flori C, Bougerol M, Le Mével S, Herrel A, Fini JB, Pézeron G, Tostivint H. Conserved role of the urotensin II receptor 4 signalling pathway to control body straightness in a tetrapod. Open Biol 2021;11:210065. [PMID: 34375549 DOI: 10.1098/rsob.210065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Nassour H, Hoang TA, Martin RD, Dallagnol JCC, Billard É, Létourneau M, Novellino E, Carotenuto A, Allen BG, Tanny JC, Fournier A, Hébert TE, Chatenet D. Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands. J Biol Chem 2021;:101057. [PMID: 34389356 DOI: 10.1016/j.jbc.2021.101057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Shen Y, Yang R, Zhou R, Lu W, Li L, Niu Z, Chen M, Wang J, Wang Y, Fang L, Du G. Xiaoxuming Decoction Regulates Vascular Function by Modulating G Protein-Coupled Receptors: A Molecular Docking Study. Biomed Res Int 2021;2021:5575443. [PMID: 34195269 DOI: 10.1155/2021/5575443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Damjanovic J, Miao J, Huang H, Lin YS. Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations. Chem Rev 2021;121:2292-324. [PMID: 33426882 DOI: 10.1021/acs.chemrev.0c01087] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
16 Cui L, Lv C, Zhang J, Li J, Wang Y. Characterization of four urotensin II receptors (UTS2Rs) in chickens. Peptides 2021;138:170482. [PMID: 33359825 DOI: 10.1016/j.peptides.2020.170482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Konno N, Takano M, Miura K, Miyazato M, Nakamachi T, Matsuda K, Kaiya H. Identification and signaling characterization of four urotensin II receptor subtypes in the western clawed frog, Xenopus tropicalis. General and Comparative Endocrinology 2020;299:113586. [DOI: 10.1016/j.ygcen.2020.113586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Nassour H, Hoang TA, Martin RD, Dallagnol JCC, Billard É, Létourneau M, Novellino E, Carotenuto A, Allen BG, Tanny JC, Fournier A, Hébert TE, Chatenet D. Membrane-tethered peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as allosteric biased ligands.. [DOI: 10.1101/2020.11.23.394270] [Reference Citation Analysis]
19 Cantaut-Belarif Y, Orts Del'Immagine A, Penru M, Pézeron G, Wyart C, Bardet PL. Adrenergic activation modulates the signal from the Reissner fiber to cerebrospinal fluid-contacting neurons during development. Elife 2020;9:e59469. [PMID: 33048048 DOI: 10.7554/eLife.59469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
20 Tüysüz ME, Bahar L. Role of Urotensin-II in Saphenous Vein Graft Disease. Braz J Cardiovasc Surg 2020;35:675-82. [PMID: 33118732 DOI: 10.21470/1678-9741-2019-0470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhang Y, Yañez Guerra LA, Egertová M, Zampronio CG, Jones AM, Elphick MR. Molecular and functional characterization of somatostatin-type signalling in a deuterostome invertebrate. Open Biol 2020;10:200172. [PMID: 32898470 DOI: 10.1098/rsob.200172] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
22 Zheng W, Ocorr K, Tatar M. Extracellular matrix induced by steroids and aging through a G-protein-coupled receptor in a Drosophila model of renal fibrosis. Dis Model Mech 2020;13:dmm041301. [PMID: 32461236 DOI: 10.1242/dmm.041301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yasmine C, Margot P, Adeline OD, Guillaume P, Claire W, Pierre-luc B. Adrenergic activation modulates the signal from the Reissner fiber to cerebrospinal fluid-contacting neurons during development.. [DOI: 10.1101/2020.05.26.117341] [Reference Citation Analysis]
24 Lu H, Shagirova A, Goggi JL, Yeo HL, Roy S. Reissner fibre-induced urotensin signalling from cerebrospinal fluid-contacting neurons prevents scoliosis of the vertebrate spine. Biol Open 2020;9:bio052027. [PMID: 32409296 DOI: 10.1242/bio.052027] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
25 Ozoux ML, Briand V, Pelat M, Barbe F, Schaeffer P, Beauverger P, Poirier B, Guillon JM, Petit F, Altenburger JM, Bidouard JP, Janiak P. Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities. J Pharmacol Exp Ther 2020;374:24-37. [PMID: 32332113 DOI: 10.1124/jpet.120.265496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Tonon M, Vaudry H, Chuquet J, Guillebaud F, Fan J, Masmoudi-kouki O, Vaudry D, Lanfray D, Morin F, Prevot V, Papadopoulos V, Troadec J, Leprince J. Endozepines and their receptors: Structure, functions and pathophysiological significance. Pharmacology & Therapeutics 2020;208:107386. [DOI: 10.1016/j.pharmthera.2019.06.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
27 Nassour H, Iddir M, Chatenet D. Towards Targeting the Urotensinergic System: Overview and Challenges. Trends in Pharmacological Sciences 2019;40:725-34. [DOI: 10.1016/j.tips.2019.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Khan K, Albanese I, Yu B, Shalal Y, Al-Kindi H, Alaws H, Tardif JC, Gourgas O, Cerutti M, Schwertani A. Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.J Thorac Cardiovasc Surg. 2019;. [PMID: 31679703 DOI: 10.1016/j.jtcvs.2019.09.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
29 Corbière A, Vaudry H, Chan P, Walet-Balieu ML, Lecroq T, Lefebvre A, Pineau C, Vaudry D. Strategies for the Identification of Bioactive Neuropeptides in Vertebrates. Front Neurosci 2019;13:948. [PMID: 31619945 DOI: 10.3389/fnins.2019.00948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Pereira-Castro J, Brás-Silva C, Fontes-Sousa AP. Novel insights into the role of urotensin II in cardiovascular disease.Drug Discov Today. 2019;24:2170-2180. [PMID: 31430542 DOI: 10.1016/j.drudis.2019.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
31 Chen X, Yin L, Jia WH, Wang NQ, Xu CY, Hou BY, Li N, Zhang L, Qiang GF, Yang XY, Du GH. Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice.Front Endocrinol (Lausanne). 2019;10:453. [PMID: 31379736 DOI: 10.3389/fendo.2019.00453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
32 Oral E, Halici Z, Cinar I, Ozcan E, Kutlu Z. Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels. Clin Psychopharmacol Neurosci 2019;17:211-21. [PMID: 30905121 DOI: 10.9758/cpn.2019.17.2.211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Zheng W, Ocorr K, Tatar M. Extra-cellular matrix induced by steroids through a G-protein coupled receptor in a Drosophila model of renal fibrosis.. [DOI: 10.1101/653329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Zhao Y, Li Y, Qu R, Chen X, Wang W, Qiu C, Liu B, Pan X, Liu L, Vasilev K, Hayball J, Dong S, Li W. Cortistatin binds to TNF-α receptors and protects against osteoarthritis. EBioMedicine 2019;41:556-70. [PMID: 30826358 DOI: 10.1016/j.ebiom.2019.02.035] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
35 Lim CJ, Kim NH, Park HJ, Lee BH, Oh KS, Yi KY. Synthesis and SAR of 5-aryl-furan-2-carboxamide derivatives as potent urotensin-II receptor antagonists. Bioorg Med Chem Lett 2019;29:577-80. [PMID: 30611618 DOI: 10.1016/j.bmcl.2018.12.058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Cioni C, Angiulli E, Toni M. Nitric Oxide and the Neuroendocrine Control of the Osmotic Stress Response in Teleosts. Int J Mol Sci 2019;20:E489. [PMID: 30678131 DOI: 10.3390/ijms20030489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Merlino F, Billard É, Yousif AM, Di Maro S, Brancaccio D, Abate L, Carotenuto A, Bellavita R, d'Emmanuele di Villa Bianca R, Santicioli P, Marinelli L, Novellino E, Hébert TE, Lubell WD, Chatenet D, Grieco P. Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides. J Med Chem 2019;62:1455-67. [PMID: 30615452 DOI: 10.1021/acs.jmedchem.8b01601] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
38 Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018;70:763-835. [PMID: 30232095 DOI: 10.1124/pr.117.015388] [Cited by in Crossref: 112] [Cited by in F6Publishing: 119] [Article Influence: 37.3] [Reference Citation Analysis]
39 Nishi M, Yonesu K, Tagawa H, Kato M, Marumoto S, Nagayama T. A Novel and Highly Potent Urotensin II Receptor Antagonist Inhibits Urotensin II–Induced Pressure Response in Mice: . Journal of Cardiovascular Pharmacology 2019;73:15-21. [DOI: 10.1097/fjc.0000000000000618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
40 Grieco P, Gomez-Monterrey I. Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials. Arch Biochem Biophys 2019;662:15-32. [PMID: 30481494 DOI: 10.1016/j.abb.2018.11.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
41 Billard E, Hébert TE, Chatenet D. Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue. J Med Chem 2018;61:8707-16. [PMID: 30183282 DOI: 10.1021/acs.jmedchem.8b00789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
42 Taddese B, Deniaud M, Garnier A, Tiss A, Guissouma H, Abdi H, Henrion D, Chabbert M. Evolution of chemokine receptors is driven by mutations in the sodium binding site. PLoS Comput Biol 2018;14:e1006209. [PMID: 29912865 DOI: 10.1371/journal.pcbi.1006209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
43 Zhang Y, Wang H, Ke J, Wei Y, Ji H, Qian Z, Liu L, Tao J. Inhibition of A-Type K+ Channels by Urotensin-II Induces Sensory Neuronal Hyperexcitability Through the PKCα-ERK Pathway. Endocrinology 2018;159:2253-63. [DOI: 10.1210/en.2018-00108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
44 Grisanti LA, Guo S, Tilley DG. Cardiac GPCR-Mediated EGFR Transactivation: Impact and Therapeutic Implications. J Cardiovasc Pharmacol 2017;70:3-9. [PMID: 28059858 DOI: 10.1097/FJC.0000000000000462] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
45 Vaudry H, Tonon MC, Vaudry D. Editorial: Trends in Regulatory Peptides. Front Endocrinol (Lausanne) 2018;9:125. [PMID: 29632516 DOI: 10.3389/fendo.2018.00125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
46 Billard É, Iddir M, Nassour H, Lee-gosselin L, Poujol de Molliens M, Chatenet D. New directions for urotensin II receptor ligands. Peptide Science 2019;111:e24056. [DOI: 10.1002/pep2.24056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
47 Vaudry H, Kah O. Editorial: Trends in Comparative Endocrinology and Neurobiology. Front Endocrinol (Lausanne) 2017;8:338. [PMID: 29250034 DOI: 10.3389/fendo.2017.00338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Douchez A, Billard E, Hébert TE, Chatenet D, Lubell WD. Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics. J Med Chem 2017;60:9838-59. [DOI: 10.1021/acs.jmedchem.7b01525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
49 Billard E, Létourneau M, Hébert TE, Chatenet D. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation. Biochemical Pharmacology 2017;144:100-7. [DOI: 10.1016/j.bcp.2017.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
50 Wu F, Song G, de Graaf C, Stevens RC. Structure and Function of Peptide-Binding G Protein-Coupled Receptors. J Mol Biol 2017;429:2726-45. [PMID: 28705763 DOI: 10.1016/j.jmb.2017.06.022] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
51 Lancien F, Vanegas G, Leprince J, Vaudry H, Le Mével JC. Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout. Front Neurosci 2017;11:51. [PMID: 28239335 DOI: 10.3389/fnins.2017.00051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Haensele E, Mele N, Miljak M, Read CM, Whitley DC, Banting L, Delépée C, Sopkova-de Oliveira Santos J, Lepailleur A, Bureau R, Essex JW, Clark T. Conformation and Dynamics of Human Urotensin II and Urotensin Related Peptide in Aqueous Solution. J Chem Inf Model 2017;57:298-310. [DOI: 10.1021/acs.jcim.6b00706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
53 Matsumoto T, Watanabe S, Kobayashi S, Ando M, Taguchi K, Kobayashi T. Age-Related Reduction of Contractile Responses to Urotensin II Is Seen in Aortas from Wistar Rats but Not from Type 2 Diabetic Goto-Kakizaki Rats. Rejuvenation Res 2017;20:134-45. [PMID: 27841739 DOI: 10.1089/rej.2016.1864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
54 Lee JH, Park BK, Oh K, Yi KY, Lim CJ, Seo HW, Lee BH. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension. International Immunopharmacology 2016;40:196-202. [DOI: 10.1016/j.intimp.2016.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
55 Cadirci E, Halici Z, Yayla M, Toktay E, Bayir Y, Karakus E, Topcu A, Buyuk B, Albayrak A. Blocking of urotensin receptors as new target for treatment of carrageenan induced inflammation in rats. Peptides 2016;82:35-43. [DOI: 10.1016/j.peptides.2016.05.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
56 Merlino F, Yousif AM, Billard É, Dufour-Gallant J, Turcotte S, Grieco P, Chatenet D, Lubell WD. Urotensin II((4-11)) Azasulfuryl Peptides: Synthesis and Biological Activity. J Med Chem 2016;59:4740-52. [PMID: 27140209 DOI: 10.1021/acs.jmedchem.6b00108] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
57 Merlino F, Brancaccio D, Yousif AM, Piras L, Campiglia P, Gomez-monterrey I, Santicioli P, Meini S, Maggi CA, Novellino E, Carotenuto A, Grieco P. Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position 9. ChemMedChem 2016;11:1856-64. [DOI: 10.1002/cmdc.201500607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
58 Vanegas G, Lancien F, Leprince J, Vaudry H, Le Mével JC. Effects of peripherally administered urotensin II and arginine vasotocin on the QT interval of the electrocardiogram in trout. Comp Biochem Physiol C Toxicol Pharmacol 2016;183-184:53-60. [PMID: 26902806 DOI: 10.1016/j.cbpc.2016.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Vanegas G, Leprince J, Lancien F, Mimassi N, Vaudry H, Le Mével JC. Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout. Front Neurosci 2015;9:142. [PMID: 25954149 DOI: 10.3389/fnins.2015.00142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
60 Bougerol M, Auradé F, Lambert FM, Le Ray D, Combes D, Thoby-Brisson M, Relaix F, Pollet N, Tostivint H. Generation of BAC transgenic tadpoles enabling live imaging of motoneurons by using the urotensin II-related peptide (ust2b) gene as a driver. PLoS One 2015;10:e0117370. [PMID: 25658845 DOI: 10.1371/journal.pone.0117370] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]